vTv Therapeutics (VTVT) Non Operating Interest Expenses (2014 - 2023)
vTv Therapeutics' Non Operating Interest Expenses was $7,000 in Q4 2023, up 16.7% from $6,000 a year earlier and up 75.0% from the prior quarter.
Powered by 
Analysis
vTv Therapeutics (VTVT) Non Operating Interest Expenses (2014 - 2023) Analysis & Trends
For FY2023, Non Operating Interest Expenses at vTv Therapeutics came in at $13,000, down 13.3% from FY2022.
- Non Operating Interest Expenses shows a five-year compound annual growth rate of -66.9% (FY2018 to FY2023).
- In earlier years, Non Operating Interest Expenses was $15,000 in FY2022 (+25.0%), $12,000 in FY2021 (-98.3%), $692,000 in FY2020 (-62.1%) and $1.83 million in FY2019 (-44.5%).
- The Q4 2023 figure marks the highest quarterly Non Operating Interest Expenses since Q3 2022.
- Compared with a year earlier, Non Operating Interest Expenses was higher in two of the last four quarters, with an average year-over-year change of 0.0%.
- The best year-over-year quarter for Non Operating Interest Expenses over five years was Q3 2022 (growth of 33.3%); the worst was Q3 2021 (a decline of 97.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 281.00 Mn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -462.00 Mn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -435.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | vTv Therapeutics | 395.24 Mn | 395.24 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Dec 31, 2022 | 6,000.00 |
| Sep 30, 2022 | 8,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 6,000.00 |
| Sep 30, 2021 | 6,000.00 |
| Dec 31, 2020 | 67,000.00 |
| Sep 30, 2020 | 235,000.00 |
| Jun 30, 2020 | 222,000.00 |
| Mar 31, 2020 | 168,000.00 |
| Dec 31, 2019 | 283,000.00 |
| Sep 30, 2019 | 404,000.00 |
| Jun 30, 2019 | 514,000.00 |
| Mar 31, 2019 | 626,000.00 |
| Dec 31, 2018 | 743,000.00 |
| Sep 30, 2018 | 822,000.00 |
| Jun 30, 2018 | 870,000.00 |
| Mar 31, 2018 | 855,000.00 |
API Access
vTv Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=VTVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "VTVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=VTVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();